Article citationsMore>>

Dananche, C., Vanhems, P., Machut, A., Aupee, M., Bervas, C., L’Heriteau, F., Lepape, A., Lucet, J.C., Stoeckel, V., Timsit, J.F., Berger-Carbonne, A., Savey, A., Benet, T. and Healthcare-Associated Infections Surveillance Network of I (2018) Trends of Incidence and Risk Factors of Ventilator-Associated Pneumonia in Elderly Patients Admitted to French ICUs between 2007 and 2014. Critical Care Medicine, 46, 869-877.
https://doi.org/10.1097/CCM.0000000000003019

has been cited by the following article:

• TITLE: Ventilator Associated Pneumonia in an Intensive Care Unit

  AUTHORS: Yadigar Yilmaz Camgoz, Ferda Yilmaz İnal, Öznur Şen

  KEYWORDS: Ventilator Associated Pneumonia, Mechanical Ventilation, Intensive Care Unit

  JOURNAL NAME: Open Journal of Respiratory Diseases, Vol.12 No.2, April 15, 2022

  ABSTRACT: The aim of this prospective study was to evaluate the incidence, etiologic agents and mortality rate of ventilator-associated pneumonia (VAP). In a six-month period, cases who were 18 years or older, dependent on mechanical ventilator for more than 3 days and without pulmonary infection on first admission were included in this study. In all cases, body temperature recordings, blood and urine culture, microbiological analyses of endotracheal aspirates, and chest X-rays were obtained and used to identify VAP. Apache II scores on admission, duration of mechanical ventilation, length of intensive care unit (ICU) stay and mortality were recorded. This study included 45 cases and 22 developed VAP (48%). The incidence of VAP was 25.34 per 1000 ventilator days. Univariate analyses showed that duration of mechanical ventilation, length of ICU stay, coma and tracheotomy were associated with the development of VAP. The mortality rate of cases with VAP (72.7%) was significantly higher than cases without VAP (39.1%). The most frequent microorganisms were Acinetobacter spp., Pseudomonas aeruginosa and Klebsiella pneumoniae. In our study, VAP was a very common and important complication of mechanical ventilation and mortality was very high. To reduce mortality, minimize morbidity, shorten the length of stay, and reduce costs, defined risk factors for VAP should be recognized and an effective infection control program for the prevention of VAP should be implemented. Surveillance results should be evaluated regularly and necessary precautions should be taken.